AI Boom Faces Reality Check as Massive Spending Meets Uncertain Returns

The artificial intelligence boom that has driven markets, corporate strategy, and investor enthusiasm over the past few years is beginning to face a critical reality check. While AI remains one of the most transformative technologies of the modern era, analysts and investors are increasingly questioning whether the enormous financial commitments pouring into the sector will […]

Intellia Jumps After Gene-Editing Therapy Succeeds in Pivotal Trial for Rare Swelling Disorder

Intellia Therapeutics rose sharply after reporting successful late-stage results for its experimental gene-editing treatment for hereditary angioedema, a rare disorder that causes dangerous and recurring swelling attacks. The company’s therapy met the main goal of its pivotal trial, helping drive shares higher. The treatment is important because it represents a major step forward for in […]

Moderna Begins Late-Stage Bird Flu Vaccine Trial in U.S. and U.K.

Moderna has begun a late-stage clinical trial of its experimental bird flu vaccine in the United States and the United Kingdom, marking a significant milestone in the effort to prepare for a possible future influenza pandemic. This is the first pandemic bird flu vaccine built with mRNA technology to reach a late-stage trial, moving the […]

Caterpillar Acquires Electric Tractor Startup Monarch in Bet on Autonomous Agriculture

Caterpillar has acquired Monarch Tractor, a California startup known for building self-driving electric tractors, in a deal that signals the industrial giant’s interest in expanding deeper into agricultural automation and cleaner equipment. The acquisition gives Caterpillar control of a company once viewed as one of the most promising startups in the ag-tech space, especially for […]

Blue Owl Expands Healthcare Real Estate Bet With $2.4 Billion Deal for Sila Realty Trust

Blue Owl Capital has agreed to acquire Sila Realty Trust in an all-cash deal valued at about $2.4 billion, expanding its push into healthcare real estate at a time when alternative asset managers are looking for steadier, income-producing assets.The acquisition will be made through Blue Owl’s real assets division and includes Sila’s portfolio of 137 […]